Expanding Therapeutic Potential with Novel Parvovirus Gene Therapy
Location: United States, Massachusetts, Boston
Employees: 11-50
Total raised: $38M
Founded date: 2021
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.06.2022 | Series A | $38M | Agent Capi... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 22.06.2022 | Carbon Biosciences Raises $38M in Series A Financing | Carbon Biosciences, a Boston, MA-based biotech company advancing novel parvovirus-derived gene thera... | finsmes.co... |
| 22.06.2022 | As the crypto winter sets in, some VCs are taking the long v... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |